A paper in JAMIA (May 2026, volume 33, issue 5) reports an open-label randomized crossover trial of two ambient AI scribe products at a tertiary academic medical center. We have read the PubMed record, not the full text, and the record does not say which products were tested.
Design and results
- 160 outpatient clinicians were randomized into two groups of 80; surveys from 136 respondents were analyzed.
- On workflow satisfaction (a 1 to 7 scale), Product B scored 2.51 against 1.91 for Product A, a difference of 0.60.
- Time spent in notes was lower with Product B by 3.19 minutes per day.
- Both tools reduced personal and work-related burnout, and the differences between the tools were not meaningful.
- No meaningful difference was found in after-hours documentation time.
The takeaway
Products in the same category can differ modestly on workflow satisfaction and time saved while looking identical on burnout. For buyers, a short head-to-head trial with your own clinicians is better evidence than vendor claims.
This is one academic centre and one study. It supports running a pilot, not a general ranking of products.